Ahmed Maher teaching hospiral
Cairo, Elsayda Zainab Square, 11617, Egypt
NCT Number: NCT05503329
To assess the prognostic value of systemic arterial lactate levels in patients with ST segment elevation myocardial infarction undergoing primary PCI and correlate with the results of primary PCI and 30 days MACE follow up.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Cairo, Elsayda Zainab Square, 11617, Egypt
All patients received the standard care for acute STEMI patients which is the primary percutaneous intervention in addition to medications.
Hyperlactemia is defined as elevated lactic acid level in the blood. The normal blood lactate level is (0.5-1 mmol/L).
All subjects were subjected to
the investigators assessed the relation between hyperlactemia and coronary flow, peak cardiac enzymes, hemodynamic parameters and MACE in 30 days follow up
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
an arterial lactate level measured from arterial sample from STEMI patients
Time frame: 30 days
we follow up occurrence of death, reinfarction, repeated hospitalization and new onset heart failure
Ahmed Maher Teaching Hospital
Other Gov
Prognostic Value of Systemic Arterial Lactate Levels in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03677466
Arterial Occlusive Diseases, Arteriosclerosis
Tomsk, Russia
View Trial DetailsNCT06154265
Arterial Occlusive Diseases, Arteriosclerosis
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05218005
Acute Coronary Syndrome, Cardiovascular Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT03439592
Cardiovascular Diseases, Communicable Diseases
Naples, Italy
View Trial Details